Evidence map›Paper›PMID 39363853›Full record

ArticleHaematologica2025

Single-cell analysis of the T-cell receptor repertoire in untreated myeloma patients suggests potential myelomareactive CD8

James Favaloro, Christian E Bryant, Edward Abadir, Samuel Gardiner, Shihong Yang, Tracy King, Najah Nassif, Bronwyn A O'Brien, Lisa M Sedger, Richard Boyle and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

James FavaloroInstitute of Hematology, Multiple Myeloma Research Laboratory, New South Wales Health Pathology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia; School of Life Sciences, University of Technology Sydney, Ultimo, New South Wales. james.favaloro@health.nsw.gov.au.
Christian E BryantInstitute of Hematology, Multiple Myeloma Research Laboratory, New South Wales Health Pathology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia; Sydney Medical School, the University of Sydney, Sydney, New South Wales.
Edward AbadirInstitute of Hematology, Multiple Myeloma Research Laboratory, New South Wales Health Pathology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia; Sydney Medical School, the University of Sydney, Sydney, New South Wales.
Samuel GardinerSydney Local Health District Clinical Research Institute, Royal Prince Alfred Hospital, Camperdown, New South Wales.
Shihong YangInstitute of Hematology, Multiple Myeloma Research Laboratory, New South Wales Health Pathology, Royal Prince Alfred Hospital, Camperdown, New South Wales.
Tracy KingInstitute of Hematology, Multiple Myeloma Research Laboratory, New South Wales Health Pathology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia; Sydney Medical School, the University of Sydney, Sydney, New South Wales.
Najah NassifSchool of Life Sciences, University of Technology Sydney, Ultimo, New South Wales.
Bronwyn A O'BrienSchool of Life Sciences, University of Technology Sydney, Ultimo, New South Wales.
Lisa M SedgerInstitute for Clinical Pathology and Medical Research (ICPMR), New South Wales Health Pathology, Westmead Hospital, Westmead, New South Wales, Australia; Center for Virus Research, Westmead Institute for Medical Research, Westmead, New South Wales.
Richard BoyleOrthopedics Department, Sydney Local Health District, Royal Prince Alfred Hospital, Camperdown, New South Wales.
Douglas E JoshuaInstitute of Hematology, Multiple Myeloma Research Laboratory, New South Wales Health Pathology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia; Sydney Medical School, the University of Sydney, Sydney, New South Wales.
P Joy HoInstitute of Hematology, Multiple Myeloma Research Laboratory, New South Wales Health Pathology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia; School of Life Sciences, University of Technology Sydney, Ultimo, New South Wales, Australia; Sydney Medical School, the University of Sydney, Sydney, NSW.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39363853
PMCPMC11788622

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.